Drug Resistant Cells
Drug-resistant cell lines are indispensable tools for unraveling the mechanisms of chemotherapeutic resistance and developing strategies to overcome it in oncology research. By mimicking the adaptive responses of tumors to therapeutic pressure, these models enable the study of resistance pathways, biomarker discovery, and high-throughput drug screening.
Creative Bioarray offers a comprehensive collection of rigorously validated drug-resistant cell lines, developed through systematic exposure to escalating doses of chemotherapeutic agents. Each cell line is characterized for stability under consistent culturing conditions, ensuring reproducible performance in long-term experiments.
Highlights of Our Drug-Resistant Cell Lines
Stability: Guaranteed consistent resistance phenotypes across passages.
Comprehensive Biobanking: Diverse portfolio covering common and rare resistance profiles.
Custom Development: Tailored solutions for specific drugs, concentrations, or genetic backgrounds.
Description: The Methotrexate-resistant cell line HT29/MTX has been developed by repeatedly exposing the parent ...
Description: The Fluorouracil-resistant cell line LoVo/5FU has been developed by repeatedly exposing the parent ...
Description: The Oxaliplatin-resistant cell line LoVo/L-OHP has been developed by repeatedly exposing the parent ...
Description: The Onvansertib-resistant cell line LoVo/Onv has been developed by repeatedly exposing the parent ...
Description: The Gemcitabine-resistant cell line ASPC-1/GEM has been developed by repeatedly exposing the parent ...
Description: The Onvansertib-resistant cell line SW620/Onv has been developed by repeatedly exposing the ...
Description: The Cisplatin-resistant cell line FADU/DDP has been developed by repeatedly exposing the parent ...
Description: The Adriamycin-resistant cell line K562/ADR has been developed by repeatedly exposing the parent ...
Description: The Imatinib-resistant cell line K562/Imatinib has been developed by repeatedly exposing the parent ...
Description: Derived from a female BALB/c myeloma tumour MPC-11. The parental cell line has mutated during ...
Description: The adriamycin-resistant cell line A2780ADR has been developed by exposure of the parent A2780 cell ...
Description: A 6-thioguanine resistant mutant of mouse L cell fibroblasts (Mouse strain C3H/An). A9 lacks ...
Description: An 8-bromodeoxyuridine resistant mutant of mouse L cell fibroblasts (Mouse strain C3H/An). B82 ...
Description: This cisplatin-resistant cell line has been developed by chronic exposure of the parent ...
Description: COR-L23/5010 has been derived from the parent line, COR-L23 by continuous exposure to increasing ...
Description: The cell line COR-L23/CPR is a drug-resistant variant of COR-L23. The line was developed by growing ...
Description: The cell line COR-L23/R is a multi-drug resistant (MDR) sub-line derived from the parent line ...
Description: The revertant lung cancer cell line COR-L23/R23- was generated by growing the doxorubicin-selected, ...